Risk Factors,PREvention and OutComes for CI-AKI in PatientS undErgoing PCI at Intensive Care Unit(PRECISE-ICU)

Risk Factors,PREvention and outComes for Contrast-Induced Acute Kidney Injury in patientS undErgoing Percutaneous Coronary Intervention at Intensive Care Unit：a Single-center Cohort Study(PRECISE-ICU)

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT03791606

Acronym

PRECISE-ICU

Enrollment

755

Registered

2019-01-02

Start date

2012-01-01

Completion date

2018-12-31

Last updated

2019-01-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

CIN

Brief summary

A retrospective, observational study included all consecutively critically ill patients undergoing percutaneous coronary intervention(PCI) at intensive care unit (ICU) in Fujian Provincial Hospital from January 1st 2012 to December 31st 2018. The aim was to determine the incidence,risk factors,prophylactic strategy and outcomes of CI-AKI in critically ill patients undergoing PCI.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Critically ill patients undergoing PCI at ICU

Exclusion criteria

* pregnancy * lactation * end-stage renal disease (eGFR \<15 mL/min/1.73 m2) * long-term dialysis treatment * intravascular administration of contrast medium within the last 7 or 3 days postoperatively

Design outcomes

Primary

Measure	Time frame	Description
CI-AKI	1 year	an absolute SCr increase ≥0.3 mg/dL or a relative increase in SCr ≥50% within 48 hours of contrast medium exposure

Secondary

Measure	Time frame	Description
in-hospital adverse events	1 year	congestive heart failure \[CHF\], bleeding, stroke, reinfarction, stent thrombosis, required renal replacement therapy, length of hospital stay, hospital costs, and mortality

Other

Measure	Time frame	Description
MACEs for long-term follow up	1 year	mortality,stent restenosis, recurrent myocardial infarction, target vessel revascularization,stroke,bleeding,required renal replacement therapy

Countries

China

Outcome results